1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSmall Business Innovation Research (SBIR) Program is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). Supports small businesses developing technologies for infectious diseases, including those impacting older adults.
Get alerted about grants like this
Save a search for “National Institute of Allergy and Infectious Diseases (NIAID)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Innovation Research and Small Business Technology Transfer Grants SOP | NIAID: National Institute of Allergy and Infectious Diseases Resources for Researchers Division of Intramural Research Labs Research at Vaccine Research Center Intramural Scientist & Clinician Directory Research Rules & Policies Allergy, Immunology & Transplantation Resources for Researchers Antimicrobial (Drug) Resistance Antimicrobial Resistance Threats Information for Researchers Risk Factors & Prevention Research Immune Tolerance Processes Disease-Specific Research Information for Researchers Autoimmune Lymphoproliferative Syndrome (ALPS) Basic & Preclinical Research Information for Researchers Information for Researchers Shiga Toxin-Producing E.
coli (STEC) Researching Ebola in Africa Information for Researchers Information for Researchers Why Food Allergy is a Priority for NIAID Characterizing Food Allergy & Addressing Related Disorders Information for Researchers Diagnosis & Management Guidelines Disease-Specific Research Information for Researchers Genomics & Advanced Technologies Pathogen-Based Initiatives Information for Researchers Information for Researchers Group A Streptococcal Infections Disease-Specific Research Information for Researchers Overview of the Immune System Features of an Immune Response Information for Researchers Information for Researchers Leprosy (Hansen's Disease) How NIAID is Addressing Lyme Disease Information for Researchers Parasite, Mosquito & Human Host Prevention, Treatment & Control Strategies Strategic Partnerships & Research Capacity Information for Researchers Information for Researchers Neglected Tropical Diseases Information for Researchers Translational & Clinical Research Cross-cutting Preparedness Molecular & Genetic Research Primary Immune Deficiency Diseases (PIDDs) Information for Researchers Animal Prion Diseases and Humans Information for Researchers Respiratory Syncytial Virus (RSV) Schistosomiasis (Bilharzia) Research in Endemic Regions Sexually Transmitted Infections (STIs) NIAID's Research Approach Information for Researchers Disease-Specific Research Information for Researchers Information for Researchers Disease-Specific Vaccines Information for Researchers Translational & Clinical Research Information for Researchers Biology, Genetics & Clinical Research NIAID's Approach to Women's Health Research Sex-Specific Health Challenges Facing Women Biennial Report (FY 2019-2020) Information for Researchers Why NIAID Is Researching Zika Virus Information for Researchers Find a Funding Opportunity Opportunities & Announcements NIAID Research Priorities Plan Your Budget & Personnel Additional Application Elements Research with Special Considerations After You Submit an Application Funding Policies and Considerations Understand the Review Process Respond to Pre-Award Requests Negotiation & Initial Award Become a Healthy Volunteer Participant's Guide to Clinical Trials HIV and Emerging Infectious Diseases Laboratory of Infectious Diseases Primary Immune Deficiency Clinic Vaccine Research Center Clinical Studies Fill Out the Volunteer Form Q&A: Vaccine Clinical Studies Vaccine Clinical Studies Safeguards Clinical Trial Publications NIAID-Funded Research News Division of Allergy, Immunology, and Transplantation Division of Microbiology and Infectious Diseases Division of Extramural Activities Division of Clinical Research Division of Intramural Research Dr. Joseph J.
Kinyoun: Father of the NIH Dr. Joseph Kinyoun The Indispensable Forgotten Man Dr. Joseph Kinyoun: Selected Bibliography NIAID 60th Anniversary Timeline Research Training at NIAID Campuses Grant Programs that NIAID Funds AIDS Research Advisory Committee AIDS Vaccine Research Subcommittee Board of Scientific Counselors Members Advisory and Peer Review Committees Autoimmune Diseases Committee Website Policies and Notices External Link Icon and Disclaimers Freedom of Information Act (FOIA) Voluntarily Submitted Information Small Business Innovation Research and Small Business Technology Transfer Grants SOP This standard operating procedure (SOP) includes the following sections: Purpose , Procedure , Contacts , and Links .
Some links will work for NIAID staff only. To fund small business grants with set-aside funds to support research and development of products or services that improve public health in areas relevant to NIAID. NIAID awards Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants with set-aside funds mandated by Congress.
Recipients of small business awards must meet the Small Business Eligibility Criteria . Only for-profit Small Business Concerns (SBCs) that have a majority ownership by U.S. citizens or permanent resident aliens can apply for small business awards.
If a legal action occurs—such as a merger, acquisition, or successor-in-interest—that changes your organization status so that it is no longer eligible for the SBIR/STTR programs, existing SBIR/STTR awards cannot be awarded additional funds. Your organization would also no longer be eligible for any new SBIR/STTR grants. Contact the NIH awarding office in advance of legal actions that may affect organizational eligibility.
For more information, refer to the NIH Grant Policy Statement , Section 8. 1. 2.
8. Change in Recipient Organizational Status . NIH will negotiate bi-lateral terminations with recipients that are ineligible to continue to receive SBIR/STTR funding.
Applicants must submit SBIR and STTR applications electronically using either the NIH Application Submission System and Interface for Submission Tracking (ASSIST) or another of the NIH Submission Options . Refer to How to Submit, Track, and View Your Application . Read the SF 424 Application Guide and the notice of funding opportunity (NOFO) for detailed instructions.
Also check Apply for a Grant . Budget: Hard Caps, Small Business Administration (SBA) Waiver, and NIAID Budget Request Limitations Total funding support (direct costs + indirect costs + fee) normally may not exceed $314,363 for Phase I awards and $2,095,748 for Phase II awards. Budget requests at or near these hard caps should be well justified.
Phase II/IIB applicants should note that NIAID will not generally allow awards (of any duration) that exceed $1 million total costs per year. NIH has received a waiver from the Small Business Administration (SBA), as authorized by the statute, to exceed the hard cap for specific topics. Applicants can find the list of approved topics at SBA-Approved Topics List for Awards over Statutory Budget Limitations .
NIAID Budget Request Limitations Unless the NOFO states otherwise, NIAID will allow Phase I applications with budgets of up to $314,363 total costs per year for up to 2 years; and Phase II or Phase IIB applications with budgets of up to $1 million total costs per year for up to 3 years. Requests for these budget levels must be very well justified.
In all cases, applicants should propose a budget that is reasonable and appropriate for completing the research project. Applications exceeding NIAID budget caps may be withdrawn from funding consideration. Applicants are strongly encouraged to contact the NIAID Small Business Program Team before submitting any application in excess of the hard caps.
NIAID staff cannot provide prior approval to exceed hard caps. At the time of award, the applicant’s grants management specialist and program officer will confirm compliance with a pre-approved topic. That does not mean that NIAID will automatically award the higher budget.
Applicants must provide an appropriate budget and justification for a budget that exceeds the SBIR/STTR hard caps. The budgets of SBIR and STTR applications will be evaluated to assess the appropriateness of the budget to the timeliness of the research goals and may be reduced on a case-by-case basis as recommended by peer reviewers, Institute/Center Advisory Board/Council, or program staff.
When making awards, NIH reserves the right to withhold or reduce grant funding on applications at any ranking based on program priority. NIH’s list eliminates the need for NIH staff to request waivers from SBA to pay awards that are greater than the hard cap for topics on the list. As referenced above under "Waiver," NIH has received approval from SBA for specific topics for budgets that exceed the hard caps.
The following are key references regarding such topics: Program Descriptions and Research Topics Document SBA-Approved Topics List for Awards over Statutory Budget Limitations The applicant is not limited to topics on the NIAID research topics list approved by SBA. All topics on the NIH list can be funded at a higher budget without a separate waiver request.
Note that NIAID supports clinical trial research performed by small businesses only through the NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44) . Go to Does your human subjects research study meet the NIH Definition of a clinical trial? to determine whether your study is a clinical trial.
Other institutes may fund clinical trials conducted by small businesses through other programs—look for NOFOs titled “Clinical Trial Required” or “Clinical Trial Optional”—but NIAID does not. Applicants, Recipients, and PIs Learn about NIAID Small Business Programs . Note: NIAID offers contract opportunities for small businesses.
To find out what’s available, go to Extramural R&D Solicitations . Identify what phase of research you are pursuing and check "Application Types Allowed" within Section II of the NOFO to verify that it supports that stage of research. Read a NOFO's recommendations on budget and length of award.
Check High-Priority Areas of Interest for NIAID’s Small Business Program for application ideas. Find SBIR and STTR application guidance on NIH’s Applying page and NIAID’s Small Business Grant Application Process . To identify an appropriate program officer to discuss scientific issues related to your proposal, email the NIAID Small Business Program Team with a brief, non-confidential summary of your planned project.
They will consult with the extramural divisions to confirm your project fits with NIAID’s mission and provide you with a contact for further discussion. If your research involves the use of federal facilities or personnel, contact the Grants Management Program to discuss requirements for collaboration with federal facilities. Advise applicants to include both science and business goals in the application.
Discuss with applicants the relevance of their project to NIAID's mission. Identify NIAID resources that may help applicants with their research. Advise your division's small business representative on unfunded SBIR and STTR applications that other institutes may fund.
Identify other institutes that may be scientifically appropriate for applications. Inform divisional representatives if you have discussed a possible transfer with other institutes. If applicants or recipients needs further guidance, refer them to the relevant divisional small business representative.
Grants Management Specialists Verify that an applicant organization qualifies as a small business. Send SBIR Funding Agreement Certification or STTR Funding Agreement Certification to the applicant. If a grant is ineligible, remove it from NPARS and notify the lead SBIR or STTR grants management staff and Director of the Office of Research Training and Special Programs.
Provide applicants with advice on NIH mandatory requirements (e.g., budget and finance, human subjects, animal welfare). Limit most awards to the caps above. Office of Research Training and Special Programs Advise potential small business applicants.
Coordinate small business awards with the NIAID Small Business Program Team and divisional small business representatives. Create an Excel spreadsheet listing all NIAID competitive SBIR and STTR applications for the fiscal year with overall impact scores and notes on intent to pay. Send the spreadsheet to divisional small business representatives.
Track the funding of competitive small business awards and share data with divisional small business representatives and DEA management.
NIAID Small Business Program Team Divisional Small Business Representatives DAIT—Michael Minnicozzi (grants); Karina Allbritton (contracts); Carmen Rios (Radiation and Nuclear Countermeasures) DMID—Barbara Mulach; Alyssa Werner Grants Management Program—Chernay Rogers; Sufiyan Saeed HHS Small Business Program Lead—Stephanie Fertig NIH Small Business Find Funding NIH Small Business Frequently Asked Questions NIAID Small Business Programs Team Roles and Agreements Resources for NIAID Staff NIAID Planning and Reporting System (NPARS) NIAID Planning and Reporting System (NPARS) SOP Release of Funds for Solicited, Opportunity Pool, and Career Transition (K99/R00) Awards SOP Repooling and Reprogramming SOP Content last reviewed on March 27, 2025
Based on current listing details, eligibility includes: Small businesses in the U.S. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Research Project Grant (Parent R01 Clinical Trial Not Allowed) is a flagship NIH grant administered by the National Institute of Allergy and Infectious Diseases that funds investigator-initiated biomedical and behavioral research projects not involving clinical trials. The R01 supports hypothesis-driven research across a wide range of health topics including infectious diseases, immune disorders, and allergy-related conditions. Eligible applicants include higher education institutions such as public and private universities. Award amounts range from $250,000 to $2,500,000 with a deadline of June 5, 2026.
Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This program supports the establishment of Tuberculosis (TB) Research Advancement Centers (TRACs) to develop the next generation of TB researchers and catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB re…
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.